日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib

体外和体内鉴定 ABCB1 为博舒替尼的外排转运体

Sara Redaelli, Pietro Perini, Monica Ceccon, Rocco Piazza, Roberta Rigolio, Mario Mauri, Frank Boschelli, Athina Giannoudis, Carlo Gambacorti-Passerini

Control of mammary tumor differentiation by SKI-606 (bosutinib).

SKI-606(博舒替尼)对乳腺肿瘤分化的控制作用

Hebbard L, Cecena G, Golas J, Sawada J, Ellies L G, Charbono A, Williams R, Jimenez R E, Wankell M, Arndt K T, DeJoy S Q, Rollins R A, Diesl V, Follettie M, Chen L, Rosfjord E, Cardiff R D, Komatsu M, Boschelli F, Oshima R G

A cell-based screen for inhibitors of protein folding and degradation

一种基于细胞的蛋白质折叠和降解抑制剂筛选方法

Frank Boschelli,Jennifer M Golas, Roseann Petersen, Vincent Lau, Lei Chen, Diane Tkach, Qiang Zhao, Dave S Fruhling, Hao Liu, Chaneun Nam, Kim T Arndt

SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells

SKI-606(博舒替尼)是一种新型 Src 激酶抑制剂,可抑制人类乳腺癌细胞的迁移和侵袭

Adina Vultur, Ralf Buettner, Claudia Kowolik, Wei Liang, David Smith, Frank Boschelli, Richard Jove

The Ydj1 molecular chaperone facilitates formation of active p60v-src in yeast

Ydj1分子伴侣促进酵母中活性p60v-src的形成

Dey, B; Caplan, A J; Boschelli, F

CDC37 is required for p60v-src activity in yeast

CDC37是酵母中p60v-src活性所必需的

Dey, B; Lightbody, J J; Boschelli, F